Using natural language processing to characterize and predict homeopathic product-associated adverse events in consumer reviews: comparison to reports to FDA Adverse Event Reporting System (FAERS)

被引:4
|
作者
Konkel, Karen [1 ,2 ,5 ]
Oner, Nurettin [2 ]
Ahmed, Abdulaziz [2 ]
Jones, S. Christopher [1 ]
Berner, Eta S. [2 ,3 ]
Zengul, Ferhat D. [2 ,3 ,4 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Div Pharmacovigilance, Off Surveillance & Epidemiol, Silver Spring, MD 20993 USA
[2] Univ Alabama Birmingham, Sch Hlth Profess, Dept Hlth Serv Adm, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Ctr Integrated Syst, Elect & Comp Engn, Birmingham, AL 35294 USA
[5] US FDA, 10903,New Hampshire Ave, Silver Spring, MD 20993 USA
关键词
natural language processing; drug safety; adverse drug event; homeopathic remedies; OTC drugs; consumer preferences;
D O I
10.1093/jamia/ocad197
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective: Apply natural language processing (NLP) to Amazon consumer reviews to identify adverse events (AEs) associated with unapproved over the counter (OTC) homeopathic drugs and compare findings with reports to the US Food and Drug Administration Adverse Event Reporting System (FAERS).Materials and methods: Data were extracted from publicly available Amazon reviews and analyzed using JMP 16 Pro Text Explorer. Topic modeling identified themes. Sentiment analysis (SA) explored consumer perceptions. A machine learning model optimized prediction of AEs in reviews. Reports for the same time interval and product class were obtained from the FAERS public dashboard and analyzed.Results: Homeopathic cough/cold products were the largest category common to both data sources (Amazon = 616, FAERS = 445) and were analyzed further. Oral symptoms and unpleasant taste were described in both datasets. Amazon reviews describing an AE had lower Amazon ratings (X-2 = 224.28, P < .0001). The optimal model for predicting AEs was Neural Boosted 5-fold combining topic modeling and Amazon ratings as predictors (mean AUC = 0.927).Discussion: Topic modeling and SA of Amazon reviews provided information about consumers' perceptions and opinions of homeopathic OTC cough and cold products. Amazon ratings appear to be a good indicator of the presence or absence of AEs, and identified events were similar to FAERS.Conclusion: Amazon reviews may complement traditional data sources to identify AEs associated with unapproved OTC homeopathic products. This study is the first to use NLP in this context and lays the groundwork for future larger scale efforts.
引用
收藏
页码:70 / 78
页数:9
相关论文
共 50 条
  • [41] Disproportionality analysis of vibegron-associated adverse events using the FDA adverse event reporting system (FAERS): a real-world pharmacovigilance study
    Bangbei Wan
    Zhi Zhou
    Ning Ma
    Weiying Lu
    European Journal of Medical Research, 30 (1)
  • [42] Evaluation of New Oral Anticoagulants (NOACs) Bleeding Adverse Reaction Reports in the FDA Adverse Events Reporting System (FAERS)
    Fahmy, Ahmed
    Mekkawy, Mohamed
    Abou-Ali, Adel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 440 - 441
  • [43] A REALWORLD PHARMACOVIGILANCE STUDY OF FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) EVENTS FOR EMPAGLIFLOZIN AND DAPAGLIFLOZIN
    Milutinovic, Stefan
    Petrovic, Marija
    Jancic, Predrag
    Trajkovic, Hristina
    Alarcon, Ricardo Orlando Escarcega
    Chazal, Richard A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 319 - 319
  • [44] Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)
    Bao, Yiwen
    Chen, Jiaju
    Duan, Luting
    Wang, Fujue
    Lai, Han
    Mo, Zeming
    Zhu, Weiliang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [45] A pharmacovigilance analysis of abrocitinib-related skin adverse events based on the FDA Adverse Event Reporting System (FAERS)
    Huang, Min
    Li, Peng
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [46] Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database
    Sato, Kenichiro
    Mano, Tatsuo
    Iwata, Atsushi
    Toda, Tatsushi
    BIOSCIENCE TRENDS, 2020, 14 (02) : 139 - 143
  • [47] Comparing adverse events of tenecteplase and alteplase: a real-world analysis of the FDA adverse event reporting system (FAERS)
    Shi, Fang-e
    Yu, Zhe
    Sun, Chengyue
    Gao, Peiliang
    Zhang, Haiyan
    Zhu, Jihong
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (02) : 221 - 229
  • [48] Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)
    Du, Yikuan
    Zhang, Mengting
    Luo, Ziyi
    Liang, Zhonghan
    Liang, Weijian
    Chen, Zhixing
    Fan, Ruiyun
    Huang, Yin
    Li, Jiaqi
    Hu, Mianda
    Li, Jiahui
    Zhu, Jinfeng
    Zhang, Weichui
    Liu, Yi
    Yang, Chun
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [49] Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
    Shu, Yamin
    Ding, Yiling
    Liu, Lulu
    Zhang, Qilin
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2705 - 2716
  • [50] Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System
    Yang, Luxuan
    Zhang, Wenyong
    Shen, Xiujuan
    Liu, Meiqin
    Wu, Meiying
    Xiao, Dan
    DRUG DISCOVERIES AND THERAPEUTICS, 2025,